Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by N00bInvesT0Ron Aug 14, 2020 8:13pm
231 Views
Post# 31411264

RE:An alternative opinion on market cap....

RE:An alternative opinion on market cap....
hevin wrote: because market cap is just the # of shares a company has X the current share price, imho it is meaningless (sorry this will upset some), and has no bearing on the real value of a company. There have been many a company with ginormous market caps, which went bankrupt; investors unfortunately forget to look at the fundamentals, the MOST important thing. Look at the massive market caps of some of the other canna companies which we know are failing, taking losses and bleeding money like a major artery has been cut. Meanwhile, Apha has 5 ebitda positive quarters and is increasing market share. We had the most revenue too. Yet our market cap is relatively small. Evidence market cap has nothing to do with value. 
In other words, if market cap had anything to do with value, ours would and should be higher than canopy's.
This doesn't mean I don't respect the other posters!
glta real investors


Agreed, company with highest market cap in a sector not always the best indeed. If you follow all the publicly traded companies of a sector in the past 10 or 20 years, you will notice that it's not the same company that stays with the highest market cap. It can even go bankrupt like you said. Due diligence important, market cap alone is not an indicator of success. Cannabis sector with recreational sales is only 2 years old. Canopy only worth alot because of Constellations drink intelligence, 2B$ cash, celebrity power and notable US presence. If you buy Canopy you paying a premium for the serious US presence. Aphria safest and most balanced in all categories, just missing the US presence to take off, US MJ companies been hot lately, Truelieve is the American Aphria.
<< Previous
Bullboard Posts
Next >>